Amicus Therapeutics, Inc. (LON:0HF9)

Amicus Therapeutics Revenue

Amicus Therapeutics had revenue of $169.06M USD in the quarter ending September 30, 2025, with 19.46% growth. This brings the company's revenue in the last twelve months to $598.70M, up 21.28% year-over-year. In the year 2024, Amicus Therapeutics had annual revenue of $528.30M with 32.29% growth.

• Revenue (ttm): $598.70M
• Revenue Growth: +21.28%
• P/S Ratio: 7.39
• Revenue / Employee: $1.20M
• Employees: 499
• Market Cap: 3.29B GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	528.30M	128.94M	32.29%
Dec 31, 2023	399.36M	70.12M	21.30%
Dec 31, 2022	329.23M	23.72M	7.76%
Dec 31, 2021	305.51M	44.63M	17.11%
Dec 31, 2020	260.89M	78.65M	43.16%
Dec 31, 2019	182.24M	90.99M	99.72%
Dec 31, 2018	91.25M	54.32M	147.08%
Dec 31, 2017	36.93M	31.97M	644.86%
Dec 31, 2016	4.96M	-	-
Dec 31, 2015	-	-	-
Dec 31, 2014	1.22M	861.00K	237.19%
Dec 31, 2013	363.00K	-18.05M	-98.03%
Dec 31, 2012	18.41M	-3.02M	-14.10%
Dec 31, 2011	21.43M	20.51M	2,224.73%
Dec 31, 2010	922.00K	-63.44M	-98.57%
Dec 31, 2009	64.36M	49.39M	330.00%
Dec 31, 2008	14.97M	13.18M	738.96%
Dec 31, 2007	1.78M	-	-
Dec 31, 2006	-	-	-
Dec 31, 2005	-	-	-